| Welcome | Share your poster with the scientific world!Welcome to ePosters.net, the open-access journal where you can share your scientific or medical poster with the world. After you present your poster at a conference or meeting you why not upload it here at ePosters.net? ePosters.net incorporates an advanced new search engine which scans all the words within the pdf allowing relevant posters to be quickly and accurately identified by researchers. Benefits of submitting your poster: - Easy and free - both submission and access are completely free of charge*
- Citation - you can cite your poster by its unique reference number and date on your résumé
- Worldwide exposure – access to your work is no longer restricted to just meeting attendees
- Easy to find - your poster can always be found using keywords or its unique reference number
- Increase collaboration - readers can contact you to discuss your work via anonymous email
- No loss of copyright – we do not require you to assign us any copyright on your material
- Reduce admin – interested viewers can print out your poster locally on their own printer
* For commercial companies there will be a small administration charge for each poster published. Quantity and sponsorship opportunities are also available. Please contact us for more information ePosters.net is now accepting submissions Sponsorship Opportunities We want the service provided by ePosters.net to be always available free of charge, thereby the ensuring widest possible sharing of new scientific work across the globe. Of course the vast potential audience for this facility should be of interest to sponsoring companies who wish to assist in the support of this service to the scientific community. For example : - Companies may wish to secure more exposure for the work (and investment) already expended in the preparation of their own posters. This can be facilitated by selecting the company name from the Sponsors drop down box on the home page.
- Conference organizers may wish to promote their meetings – over and above the free reciprocal arrangements we offer – by means of a banner ad either on the top of the home page or at the side of internal pages.
If you want to learn more about how your company could benefit from the opportunities available on ePosters.net please email us for more information. |
| | | | Program Development Manager, LasX Industries, MN, USA LasX Industries
The position of Program Development Manager assumes the lead role for developing production processes for targeted programs, primarily in the micro-fluidics market. | Assistant/Associate Professors Chinese University of Hong Kong
The newly established School of Biomedical Sciences, Stem Cell and Regeneration theme is actively looking for stem cell biologist over the next 2 years. | Engineer Technician, Fayetteville, Arizona, USA SFC-Fluidics
SFC Fluidics is looking to hire a highly motivated, detail-oriented engineer technician.
oral communication skills . Experience with GMP and GLP desired | Computational Medicinal Chemistry Post-Doc Position, Siena, Italy University of Siena
NatSynDrugs Is Seeking Candidates For a Computational Medicinal Chemistry Post-Doc Position | Senior Scientist, Metabolism Agios
Agios Pharmaceuticals is seeking a PhD Scientist to join a team that is building and applying a state-of-art approach to investigate the intersection of cancer cell biology and metabolism.
| Automation Engineer, Metabolism, Agios Pharmaceuticals, Cambridge, MA, USA Agios Pharmaceuticals
With new research showing that cancer cells become addicted to using more nutrients than normal cells to promote their rapid growth, there is an unprecedented opportunity to create a new class of oncology therapeutics that target a fundamental and ubiquitous mechanism in cancer cells. The intersection of these two fields of research - cancer and metabolism- represents an important and novel approach to treating cancer.
| Post-doctoral position at INRA (France) INRA
An 18-month post-doctoral position is available at INRA Clermont-Ferrand-Theix (France).The position is opened to both French and foreign applicants. | US Field Application Scientist, Cell based assay technology Langton Howarth
Our client supplies novel laboratory scale instrumentation, screening services and develops custom automation for life sciences companies spanning the healthcare, biotech and pharmaceutical sectors.
Due to expansion they now seek a US Field Application Scientist to support sales and customers of their high content screening/cell based assay technology. |
| | | An Emerging Revolution in Automated 3D Cell Culture Merck Research Laboratories,University of Virginia, BioCell Cubed
Market pressure exists for new paradigms to meet the demands for more rapid and reproducible cell production to keep up with advances in cell-based assays used in drug discovery and development. Novel automation platforms enable high productivity on three dimensional surfaces. | Development of a Lab-on-a-Chip for the Characterization of Human Cells ARC and Nano-Systemtechnologies
Cell chips are developed to continuously monitor mammalian cell population dynamics in a non-invasive manner. In the presented work we describe the design, fabrication and characterization of a lab-on-a-chip for quantitative cell analysis. | Bio-analytic silicon chips for the detection of developmentalneurotoxic effects of chemicals and drugs in the context of the European REACH program University of Rostock, Bionas GmbH
Bio-analytic silicon chips can be used to investigate stem cell differentiation into neurons and for the in vitro on-line monitoring of cellular reactions under well controlled experimental conditions. Chip systems allow for a parallel, label-free and non-invasive measurement of different parameters by CMOS silicon microsensors by the application of potential neurotoxic and developmental neurotoxic substances. | RNA Interference in Mammalian Cells Using low siRNA Concentrations QIAGEN
We have developed a transfection reagent, HiPerFect Transfection Reagent, which allows efficient gene knockdown with siRNA concentrations from 1 nM–10 nM, depending on the cell type and siRNA used. HiPerFect Transfection Reagent has been tested and validated for many cell types, including primary cells. Effective knockdown in primary cells demonstrates that HiPerFect Transfection Reagent ensures low cytotoxicity levels. |
|
|
|
|
| | 6th Compound Management & Integrity Summit IQPC
| Next Generation Sequencing & Genomic Medicine Applications Summit IBC
Integrating Genomic and Clinical Studies to Improve Disease Models, Drug/Diagnostic Development and Patient Care
Learn more about:
• Immunogenetics and next generation sequencing
• Applications in cancer drug and diagnostic development
• Non-cancer applications; Strategies for large-scale data integration and analysis
Register at www.IBCLifeSciences.com/sequencing, save 20% off standard rates, use priority code: D10201TN. | Empowered Antibody Therapies IBC
Modified Antibodies, Conjugation Strategies and Bispecific/ Multifunctional Constructs
Learn more about:
• Engineering more potent, efficacious and multifunctional antibody drugs
• Novel warheads, linkers, payloads and modifications
• Clinical results and lessons from ADC’s and bispecifics in development
Register at www.IBCLifeSciences.com/antibody, save 20% off standard rates, use priority code: D10201TN. | Cancer Genomics & Cancer Mutations IBC
Personalizing Cancer Medicine: Strategies for Drug and Diagnostic Development
Learn more about:
• New approaches for targeting cancers and personalizing treatment regimens
• Exploiting the expressed tumor genome and DNA structure/sequence
• Breaking news from cancer genome consortia and clinical projects
Register at www.IBCLifeSciences.com/cancergenomics, save 20% off standard rates, use priority code: D10201TN. | Cancer Stem Cells & the Tumor Microenvironment IBC
Exploiting CSC's, Inflammation and Stromal Support of Tumors for Therapeutic Intervention
Learn more about:
• Therapeutics targeting the inflammatory component of tumors
• Data from cancer stem cell-targeted drugs in development
• New insights on stromal support of tumors and the tumor microenvironment
Register at www.IBCLifeSciences.com/cancermicro, save 20% off standard rates, use priority code: D10201TN. | MA Payer/Provider Collaborative Care Summit Opal Events
Opal Events is pleased to announce our latest medical management conference, which will focus on the strategic implementation of “next generation” medical management tactics such as Accountable Care Organizations, Medical Homes, Transitional Care, and more! | BioBanking 2010 IQPC
IQPC’s 3rd Biobanking Conference taking place August 19-20 in San Diego, CA will address the key challenges facing biorepositories. This exciting event will also include a site tour actual BioBank. For more information visit www.biobankingconference.com | Ubiquitin Drug Discovery & Diagnostics 2010, Philadelphia PA Life Sensors
The ubiquitin story continues to grow as more companies exploit this critical regulatory pathway for the discovery and development of therapeutics. | Drug Discovery: Easing the Bottleneck Opal Events
Join over 100 industry professionals, government officials and academics for the 2nd Annual Drug Discovery: Easing the Bottleneck Conference this August 23-24 at the Loews Hotel, in Philadelphia, Pennsylvania. |
|
|